Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000711345 | SCV000841696 | uncertain significance | not provided | 2017-12-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000711345 | SCV002168360 | uncertain significance | not provided | 2021-10-27 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, a(n) neutral and polar amino acid, with methionine, a(n) neutral and non-polar amino acid, at codon 5 of the GJB2 protein (p.Thr5Met). This variant is present in population databases (rs781085903, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with GJB2-related conditions. ClinVar contains an entry for this variant (Variation ID: 585738). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002493261 | SCV002781572 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 1A; Mutilating keratoderma; Ichthyosis, hystrix-like, with hearing loss; Autosomal dominant keratitis-ichthyosis-hearing loss syndrome; Palmoplantar keratoderma-deafness syndrome; Knuckle pads, deafness AND leukonychia syndrome; Autosomal dominant nonsyndromic hearing loss 3A; X-linked mixed hearing loss with perilymphatic gusher | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001830575 | SCV002086074 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 1A | 2021-03-12 | no assertion criteria provided | clinical testing |